Correlation Between Intel and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intel and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Spyre Therapeutics, you can compare the effects of market volatilities on Intel and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Spyre Therapeutics.
Diversification Opportunities for Intel and Spyre Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Intel and Spyre is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Intel i.e., Intel and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Intel and Spyre Therapeutics
Given the investment horizon of 90 days Intel is expected to generate 0.74 times more return on investment than Spyre Therapeutics. However, Intel is 1.35 times less risky than Spyre Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 2,346 in Intel on August 29, 2024 and sell it today you would lose (20.50) from holding Intel or give up 0.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intel vs. Spyre Therapeutics
Performance |
| Timeline |
| Intel |
| Spyre Therapeutics |
Intel and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intel and Spyre Therapeutics
The main advantage of trading using opposite Intel and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Intel vs. ABIVAX Socit Anonyme | Intel vs. Morningstar Unconstrained Allocation | Intel vs. SPACE | Intel vs. Knife River |
| Spyre Therapeutics vs. Bright Minds Biosciences | Spyre Therapeutics vs. HP Inc | Spyre Therapeutics vs. Intel | Spyre Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |